Nevertheless, we experimentally demonstrated herein that this polymorphism affects the binding spectrum of the nuclear proteome to the FNTB promoter region in luminal and triple negative breast cancer cell lines and is therefore likely to modulate FNTB transcriptional activity, comparable with FNTB-609 G/C. Here, FNTB is linked to triple-negative breast carcinoma.